Organometallics
Article
isolated as a highly insoluble dark green solid. Yield: 452.0 mg
(>99%). 1H NMR (500 MHz, DMSO-d6): δ 8.43 (br s, 2H, CHpyrene),
8.27 (br s, 4H, NCHN), 8.08 (br s, 4H, CHpyrene), 7.85 (br s, 2H,
CHimid), 7.36 (br s, 2H, CHimid). Electrospray MS (cone 20 V) (m/z,
fragment): 467.2 [M + H]+ (calc. for [M + H]+: 467.2).
the tetra-iridium complex (4) shows higher activity than the
tetra-rhodium one (3). Although there is clearly room for
improvement, to the best of our knowledge, complex 4 is the
first iridium complex tested in this reaction.
Synthesis of the Tetra-imidazolium Salt 2. Under aerobic
conditions, a mixture of compound 1 (517 mg, 1.11 mmol, 1
equiv) and n-BuI (16 mL, 89 mmol, 80 equiv) was heated in a thick-
walled Schlenk tube fitted with a Teflon cap at 100 °C for 72 h. After
cooling at room temperature, the excess of n-BuI was distilled under
vacuum. The resulting black solid residue was washed several times
with diethyl ether and ethyl acetate, and collected by filtration. The
iodide salt (500 mg, 0.42 mmol, 1 equiv) was dissolved in MeOH (15
mL) and treated with [NH4](PF6) (342.3 mg, 2.10 mmol, 5 equiv).
The suspension was heated at 40 °C overnight. Compound 2 was
EXPERIMENTAL SECTION
■
General Considerations. Anhydrous solvents were dried using a
solvent purification system (SPS M BRAUN) or purchased and
degassed prior to use by purging them with dry nitrogen. All the
reagents and solvents were used as received from commercial
suppliers. Column chromatography was performed on silica gel
Merck 60, 62−200 mm unless otherwise stated, using mixtures of
solvents. NMR spectra were recorded on a Varian Innova 500 MHz or
on a Bruker 400/300 MHz, using DMSO-d6, acetone-d6, or CDCl3 as
solvent. Elemental analyses were carried out on a TruSpec Micro
Series. Infrared spectra (FT-IR) were performed on a Bruker
EQUINOX 55 spectrometer with a spectral window of 4000−600
cm−1. Electrospray Mass Spectra (ESI-MS) were recorded on a
Micromass Quatro LC instrument. MeOH, CH3CN, or CH2Cl2 was
used as mobile phase, and nitrogen was employed as the drying and
nebulizing gas.
1
collected by filtration as a brown solid. Yield: 885 mg (71%). H
NMR (400 MHz, acetone-d6): δ 9.72 (s, 4H, NCHN), 9.06 (s, 2H,
CHpyr), 8.49 (s, 4H, CHpyr), 8.31 (s, 4H, CHimid), 8.26 (s, 4H,
3
CHimid), 4.62 (t, JH‑H = 8 Hz, 8H, NCH2CH2CH2CH3), 2.18−2.10
(m, 8H, NCH2CH2CH2CH3), 1.58−1.49 (m, 8H, NCH2CH2CH2-
3
CH3), 1.02 (t, JH‑H = 8 Hz, 12H, NCH2CH2CH2CH3). 19F{1H}
NMR (376 MHz, CDCl3): δ −72.3 (d). 31P{1H} NMR (162 MHz,
CDCl3): δ −144.4 (m). 13C{1H} NMR (100 MHz, acetone-d6): δ
139.1 (NCHN), 131.2 (Cq pyr), 128.8 (Cq pyr), 126.9 (CHpyr), 126.4
(CHpyr), 125.9 (CHimid), 125.2 (Cq pyr), 124.8 (CHimid), 51.3
(NCH2CH2CH2CH3), 32.5 (NCH2CH2CH2CH3), 20.2 (NCH2-
CH2CH2CH3), 13.7 (NCH2CH2CH2CH3). Electrospray MS (cone
20 V) (m/z, fragment): 173.7 [M − 4(PF6)]4+, 279.9 [M −
3(PF6)]3+, 492.3 [M − 2(PF6))]2+ (calcd. for [M − 4(PF6)]4+: 173.6,
[M − 3(PF6)]3+: 279.8, [M − 2(PF6))]2+: 492.2). Anal. Calcd for
C44H54N8P4F24·2CH2Cl2 (1444.68): C, 38.24; H, 4.05; N, 7.76.
Found: C, 38.43; H, 3.92; N, 7.82.
Synthesis of the Rh(I) and Ir(I) Complexes. Synthesis of 1-n-
Butyl-3-phenylimidazolium Hexafluorophosphate. Imidazole (1.3
g, 19.6 mmol, 4 equiv), CuSO4 (196 mg, 1.23 mmol, 0.25 equiv), and
K2CO3 (2 g, 14.7 mmol, 3 equiv) were placed together in a high
pressure Schlenk tube fitted with a Teflon cap. The tube was
evacuated and filled with nitrogen three times. Iodobenzene (0.56
mL, 4.9 mmol, 1 equiv) was added, and the resulting suspension was
heated at 150 °C for 24 h. After this time, the resulting solid was
washed with water (3 × 40 mL) and filtrated using a Buchner. The
̈
solid was extracted with MeOH (3 × 20 mL). 1-Phenylimidazole,
which was isolated as an oil after removal of the volatiles, was
employed in the next step without further purification. Yield: 400 mg
(57%). A mixture of 1-phenylimidazole (400 mg, 2.8 mmol, 1 equiv)
and n-BuI (0.3 mL, 2.8 mL, 1 equiv) in dry THF (20 mL) was heated
at 110 °C in a high pressure Schlenk tube fitted with a Teflon cap,
during 12 h. After removal of the volatiles, 1-n-butyl-3-phenyl-
imidazolium iodide was isolated as a brown oil. A mixture of 1-n-
butyl-3-phenylimidazolium iodide (885 mg, 2.7 mmol, 1 equiv) and
[NH4](PF6) (550 mg, 3.4 mmol, 1.25 equiv) in MeOH (15 mL) was
heated at 40 °C overnight. After removal of the volatiles, the crude
was washed with dichloromethane and the insoluble salts were
separated by filtration. The desired product was isolated as an off-
white solid after precipitation in a mixture dichloromethane/diethyl
ether. Yield: 900 mg (93%). 1H NMR (400 MHz, CDCl3): δ 9.08 (s,
1H, NCHN), 7.61−7.48 (m, 7H; 5H, CHphenyl and 2H, CHimid), 4.36
Synthesis of the Tetrametallic Complexes 3−5. General
Procedure for Complexes 3 and 4. Compound 2 (1 equiv) was
placed in a Schlenk tube. The tube was evacuated and filled with
nitrogen three times. The solid was suspended in dry CH3CN and
NEt3 (50 equiv) was added to the suspension. The resulting solution
was heated at 40 °C for 45 min. The corresponding metal precursor
(2.2 equiv of [RhCl(cod)]2 or [IrCl(cod)]2) was placed in a second
Schlenk tube. The tube was evacuated and filled with nitrogen three
times. The solid was then suspended in dry CH3CN and subsequently
cannulated over the first Schlenk. The resulting mixture was heated
under reflux overnight. Once at room temperature, the resulting
yellow precipitate was collected by filtration. The crude product was
purified by column chromatography. Elution with a 9:1 CH2Cl2/
acetone mixture afforded a bright red band that contained the desired
complex.
3
Synthesis of 3. A mixture of [RhCl(cod)]2 (127.8 mg, 0.260
mmol) in dry CH3CN (10 mL) was cannulated to a suspension of 2
(150 mg, 0.118 mmol) and NEt3 (0.82 mL, 5.9 mmol) in dry CH3CN
(30 mL). After the general workup, complex 3 was isolated as a bright
yellow solid. Yield: 107.1 mg (54%). 1H NMR (300 MHz, CDCl3): δ
9.86 (d, 3JH‑H = 7 Hz, 2H, CHpyr), 8.98 (s, 2H, CHpyr), 8.15 (d, 3JH‑H
(t, JH‑H = 8 Hz, 2H, NCH2CH2CH2CH3), 1.98−1.91 (m, 2H,
NCH2CH2CH2CH3), 1.46−1.40 (m, 2H, NCH2CH2CH2CH3), 0.98
(t, 3JH‑H = 8 Hz, 3H, NCH2CH2CH2CH3). 19F{1H} NMR (376 MHz,
CDCl3): δ −72.3 (d). 31P{1H} NMR (162 MHz, CDCl3): δ −144.32
(m). 13C{1H} NMR (100 MHz, CDCl3): δ 134.4 (NCHN), 134.3
(Cq phenyl), 130.7 (CHphenyl), 127.8 (CHphenyl), 123.1 (CHimid), 122.3
(CHphenyl), 121.5 (CHimid), 50.6 (NCH2CH2CH2CH3), 31.9 (NCH2-
CH2CH2CH3), 19.5 (NCH2CH2CH2CH3), 13.4 (NCH2CH2CH2-
CH3). Electrospray MS (cone 20 V) (m/z, fragment): 201.2 [M −
PF6]+ (calcd. for [M − PF6]+: 201.3). Anal. Calcd for C13H17N2PF6·
CH2Cl2 (431.18): C, 39.00; H, 4.44; N, 6.50. Found: C, 39.42; H,
4.18; N, 6.99.
3
= 1.5 Hz, 2H, CHimid), 8.11 (d, JH‑H = 7 Hz, 2H, CHpyr), 7.40 (d,
3JH‑H = 1.5 Hz, 2H, CHimid), 7.21 (d, 3JH‑H = 1.5 Hz, 2H, CHimid), 7.20
3
(d, JH‑H = 1.5 Hz, d, 2H, CHimid), 5.27−5.21 (m, 4H, NCH2-
CH2CH2CH3), 4.88−4.78 (m, 8H, CHcod), 4.71−4.61 (m, 8H,
CHcod), 4.50−4.43 (m, 4H, NCH2CH2CH2CH3), 3.35 (q, 3H,
CH2 cod), 3.29 (q, 3H, CH2 cod). The rest of the signals corresponding
to the n-butyl and cod ligands are displayed in the region between
2.50 and 0.30 ppm. 13C{1H} NMR (75 MHz, CDCl3): δ 185.5 (d,
Synthesis of the Neutral Precursor 1. A mixture of 1,3,6,8-
tetrabromopyrene (500 mg, 0.97 mmol, 1 equiv), imidazole (265.6
mg, 3.86 mmol, 4 equiv), K2CO3 (1079 mg, 7.73 mmol, 8 equiv), and
CuI (73.6 mg, 0.39 mmol, 0.4 equiv) were placed together in a high
pressure Schlenk tube fitted with a Teflon cap. The tube was
evacuated and filled with nitrogen three times. The solids were
suspended in anhydrous DMF (12 mL), and the resulting solution
was heated at 160 °C for 72 h. Then, the reaction mixture was allowed
to reach room temperature. Distilled water (75 mL) was added, and
the suspension was stirred for 2 h. The resulting solid was collected by
1
1
Rh-Ccarbene, JRh‑C = 51 Hz), 183.6 (d, Rh-Ccarbene, JRh‑C = 51 Hz),
134.4 (Cq pyr), 134.4 (Cq pyr), 128.1 (CHimid), 127.6 (CHimid), 127.3
(Cq pyr), 127.0 (Cq pyr), 125.5 (CHimid), 125.1 (Cq pyr), 123.9 (CHimid),
122.1 (CHpyr), 121.8 (CHpyr), 121.7 (CHpyr), 98.3 (d, Rh-CHcod
,
1
1JRh‑C = 6.75 Hz), 98.1 (d, Rh-CHcod, JRh‑C = 6.75 Hz), 97.5 (d, Rh-
CHcod, 1JRh‑C = 7.5 Hz), 96.9 (d, Rh-CHcod, 1JRh‑C = 7.5 Hz), 69.7 (d,
Rh-CHcod, 1JRh‑C = 14.25 Hz), 69.4 (d, Rh-CHcod, 1JRh‑C = 14.25 Hz),
68.7 (d, Rh-CHcod, 1JRh‑C = 13.5 Hz), 66.6 (d, Rh-CHcod, 1JRh‑C = 13.5
Hz), 52.0 (NCH2CH2CH2CH3), 51.1 (NCH2CH2CH2CH3), 35.06
filtration using a Buchner and washed with water. Compound 1 was
̈
E
Organometallics XXXX, XXX, XXX−XXX